IN-B00009

IN-B00009 · HK inno.N Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IN-B00009, covering 2025-12-29 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone [Phase 3]

See pricing